XENE

NASDAQ · Biotechnology

Xenon Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$54.94

-0.23 (-0.42%)

As of Mar 22, 9:58 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 26 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target -63.6% upside

Low Target $12.55

Average Target $19.98

High Target $22.13

Current Price $54.94

Current
$54.94

Target
$19.98

$12.55 $19.98 avg $22.13

Scenario Analysis

Bear Case

$12.55

-77.2%

Low target

Base Case

$19.98

-63.6%

Avg target

Bull Case

$22.13

+-59.7%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$63.95

-14.1% from high

52-Week Low

$26.74

+105.5% from low

50-Day SMA

$42.54

+29.1% vs SMA

200-Day SMA

$37.78

+45.4% vs SMA

RSI (14)

57.5

Neutral

Target vs 52W High

$19.98

-68.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+25.5%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.2%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-66.8%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	+3.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-26.5%